Jubilant Pharmova Q3 Results

  • BSE: 530019
  • NSE: JUBLPHARMA
  • ISIN: INE700A01033
  • Sector: Biotechnology & Drugs
BSE
7458.10 (1.10%)
Volume8.24 K
Updated: Thu 13 Jun, 2024 | 15:29:20
NSE
74810.85 (1.47%)
Volume3.03 L
Updated: Thu 13 Jun, 2024 | 15:29:55
Today: 736.75
762.70
52-Wk: 319.30
770.65

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Jubilant Pharmova Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 1,677.101,680.30-0.19%1,552.518.03%
    Selling/ General/ Admin Expenses Total 581.50531.809.35%567.942.39%
    Depreciation/ Amortization 94.6096.60-2.07%94.280.34%
    Other Operating Expenses Total 341.70349.40-2.20%360.62-5.25%
    Total Operating Expense 1,553.701,535.101.21%1,500.913.52%
    Operating Income 123.40145.20-15.01%51.60139.15%
    Net Income Before Taxes 101.0098.003.06%8.731056.93%
    Net Income 66.8062.506.88%-15.670.00%
    Diluted Normalized EPS 4.203.946.60%-0.980.00%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App